CONSOLIDATED STATEMENTS OF EARNINGS (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
EARNINGS
Net Sales	$ 21,244	$ 19,484	$ 18,808
Cost of products sold	5,598	5,277	5,140
Marketing, selling and administrative	4,203	3,686	3,946
Advertising and product promotion	957	977	1,136
Research and development	3,839	3,566	3,647
Provision for restructuring	116	113	136
Litigation expense, net		(19)	132
Equity in net income of affiliates	(281)	(313)	(550)
Other (income)/expense	(169)	126	(381)
Total Expenses	14,263	13,413	13,206
Earnings from Continuing Operations Before Income Taxes	6,981	6,071	5,602
Provision for income taxes	1,721	1,558	1,182
Net Earnings from Continuing Operations	5,260	4,513	4,420
Discontinued Operations:
Earnings, net of taxes			285
Gain on disposal, net of taxes			7,157
Net Earnings from Discontinued Operations			7,442
Net Earnings	5,260	4,513	11,862
Net Earnings Attributable to Noncontrolling Interest	1,551	1,411	1,250
Net Earnings Attributable to Bristol-Myers Squibb Company	3,709	3,102	10,612
Amounts Attributable to Bristol-Myers Squibb Company
Net earnings from continuing operations attributable to Bristol-Myers Squibb Company	3,709	3,102	3,239
Net earnings from discontinued operations attributable to Bristol-Myers Squibb Company			$ 7,373
Earnings per Common Share
Basic Earnings per Common Share from Continuing Operations Attributable to Bristol-Myers Squibb Company	$ 2.18	$ 1.80	$ 1.63
Diluted Earnings per Common Share from Continuing Operations Attributable to Bristol-Myers Squibb Company	$ 2.16	$ 1.79	$ 1.63
Basic Earnings Per Common Share Attributable to Bristol-Myers Squibb Company	$ 2.18	$ 1.80	$ 5.35
Diluted Earnings per Common Share Attributable to Bristol-Myers Squibb Company	$ 2.16	$ 1.79	$ 5.34
Dividends declared per common share	$ 1.33	$ 1.29	$ 1.25